<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04905628</url>
  </required_header>
  <id_info>
    <org_study_id>PTL-904284</org_study_id>
    <nct_id>NCT04905628</nct_id>
  </id_info>
  <brief_title>Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus</brief_title>
  <official_title>Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DexCom, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DexCom, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With&#xD;
      Diabetes Mellitus&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 8, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dexcom Continuous Glucose Monitoring (CGM) System Performance</measure>
    <time_frame>10 Days</time_frame>
    <description>The Dexcom Continuous Glucose Monitoring (CGM) System performance will be assessed compared to Yellow Springs Instrument (YSI) comparator venous plasma measurements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>System Related Adverse Device Effects</measure>
    <time_frame>10 Days</time_frame>
    <description>The Dexcom Continuous Glucose Monitoring (CGM) System will be characterized by Adverse Device Effects experienced by study participants</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Dexcom CGM System</arm_group_label>
    <description>Dexcom CGM System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dexcom CGM System</intervention_name>
    <description>Dexcom CGM System</description>
    <arm_group_label>Dexcom CGM System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1. Age ≥ 18 years&#xD;
&#xD;
          2. Confirmed pregnancy&#xD;
&#xD;
          3. Diagnosis of Gestational Diabetes (GDM), Type 1 Diabetes Mellitus (T1DM), or Type 2&#xD;
             Diabetes Mellitus (T2DM)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Confirmed pregnancy&#xD;
&#xD;
          -  Diagnosis of Gestational Diabetes (GDM), Type 1 Diabetes Mellitus (T1DM), or Type 2&#xD;
             Diabetes Mellitus (T2DM)&#xD;
&#xD;
          -  Willing to wear up to the required number of Systems for the total duration of study&#xD;
             wear&#xD;
&#xD;
          -  Able to follow study procedures;&#xD;
&#xD;
          -  Able to speak, read, and write in English or Spanish.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Extensive skin changes/diseases that preclude wearing the required number of Systems&#xD;
             at the proposed wear sites&#xD;
&#xD;
          -  Known allergy to medical-grade adhesives&#xD;
&#xD;
          -  Hematocrit outside specification&#xD;
&#xD;
          -  Prescribed drugs for treatment of pre-term labor or experiencing high-risk pregnancy&#xD;
             complications during current pregnancy&#xD;
&#xD;
          -  Currently receiving dialysis treatment or planning to receive dialysis during the&#xD;
             sensor wear period&#xD;
&#xD;
          -  Currently using Hydroxyurea for treatment&#xD;
&#xD;
          -  Require a Magnetic Resonance Imaging (MRI) scan, Computed Tomography (CT) scan, or&#xD;
             diathermy during the sensor wear period&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carol Levy, MD, CDCES</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sarit Polsky,, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barbara Davis Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Florence Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Joslin Diabetes Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kristin Castorino, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sansum Diabetes Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amy Valent, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stayce Beck, PhD, MPH</last_name>
    <phone>858-203-6454</phone>
    <email>PTL904284@dexcom.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nelly Njeru</last_name>
    <phone>858-203-6379</phone>
    <email>PTL904284@dexcom.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sansum Diabetes Research Institute</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nina Shelton</last_name>
      <email>nshelton@sansum.org</email>
    </contact>
    <investigator>
      <last_name>Kristin Castorino, D.O.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barbara Davis Center for Childhood Diabetes</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christie Beatson, RD, CDE</last_name>
      <email>CHRISTIE.BEATSON@CUANSCHUTZ.EDU</email>
    </contact>
    <investigator>
      <last_name>Sarit Polsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joslin Diabetes Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julianne O'Connell</last_name>
      <email>julianne.oconnell@joslin.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Florence Brown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selassie Ogyaadu</last_name>
      <email>selassie.ogyaadu@mssm.edu</email>
    </contact>
    <investigator>
      <last_name>Carol Levy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Rincon</last_name>
      <email>mfmresearch@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Amy Valent, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>May 24, 2021</study_first_submitted>
  <study_first_submitted_qc>May 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

